| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.92 | 1e-06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.77 | 3e-05 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.77 | 3e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 4e-05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |